Skip to Main Content

Paper Details

Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk.
Prostate Cancer Prostatic Dis
12
2022
Author NameAffiliation
Arun A Azad
Arun A AzadPeter MacCallum Cancer Centre
Arnulf StenzlEberhard Karls University of Tubingen
  • 1 - 3

Datasets

Release 1.2